Prescription opioid dependence is associated with poorer outcomes in disabling spinal disorders

Spine

Volumn 33, Issue 20, 2008, Pages 2219-2227

  Dersh, Jeffrey ^a   Mayer, Tom G ^b,d   Gatchel, Robert J ^c   Polatin, Peter B ^a   Theodore, Brian R ^a   Mayer, Eric A K ^a  

^a PRIDE Research Foundation   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^d NONE   (United States)

Author keywords

Chronic pain; Disabling occupational spinal disorders; Functional restoration rehabilitation; Interdisciplinary pain programs; Occupational medicine; Opioid dependence; Return to work; Socioeconomic outcomes; Workers compensation

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DETOXIFICATION; DISABILITY; DISEASE ASSOCIATION; DRUG DEPENDENCE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OPIATE ADDICTION; PAIN; PATIENT REFERRAL; POPULATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK; RISK FACTOR; SPINE DISEASE; TREATMENT OUTCOME; WORK; DISABLED PERSON; MEDICAL LEAVE; OCCUPATIONAL DISEASE; PAIN ASSESSMENT; PATIENT ATTITUDE; PROSPECTIVE STUDY; SPINE INJURY;

ADULT; ANALGESICS, OPIOID; DISABLED PERSONS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; OCCUPATIONAL DISEASES; OPIOID-RELATED DISORDERS; PAIN; PAIN MEASUREMENT; PATIENT ACCEPTANCE OF HEALTH CARE; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; SICK LEAVE; SPINAL INJURIES;

EID: 55449093023     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31818096d1     Document Type: Article

References (92)

1. Cats-Baril W. The cost of low back pain. Paper presented, at: Travelers Insurance Low Back Pain Symposium; 1996; St. Louis, MO.
2. Frymoyer JW. Epidemiology of spinal disease. In: Mayer TG, Mooney V, Gatchel RJ, eds. Contemporary Conservative Care for Painful Spinal Disorders. Philadelphia, PA: Lea & Febiger; 1991.
3. Jolinder PO, Nota DF. Early return to work following an aggressive rehabilitation program initiated one day after spine surgery. J Occup Rehabil 1994; 4:211-28.
4. Andersson GBJ, Pope MH, Frymoyer JW, et al. Occupational low back pain: assessment, treatment, and prevention. In: Pope MH, Anderrson GBJ, Frymoyer JW, et al, eds. Epidemiology and Cost. St. Louis, MO: Mosby-Year Book; 1991.
5. Rizzo JA, Abbott TA, HI, Berger ML. The labor productivity effects of chronic backache in the United States. Med Care 1998;36:1471-88.
6. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002;18:355-65.
7. Straus BN. Chronic pain of spinal origin: the costs of intervention. Spine 2002;27:2614-9; discussion 2620.
8. Kornick CA, Santiago-Palma J, Moryl N, et al. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf: Int J Med Toxicol Drug Exp 2003;26:951-73.
9. National survey on drug use and health. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; Rockville, MD. Available at: http://www.oas.samhsa.gov/nhsda.htmtt NHSDAinfo. Accessed February 15, 2005.
10. Franklin GM, Mai J, Wickizer T, et al. Opioid dosing trends and mortality in Washington State workers' compensation 1996-2002. Am J Ind Med 2005; 48:91-9.
11. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002;23:131-7.
12. Fanciullo GJ, Ball PA, Girault G, et al. An observational study on the prevalence and pattern of opioid use in 25,479 patients with spine and radicular pain. Spine 2002;27:201-5.
13. Luo X, Pietrobon R, Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine 2004;29:884-890; discussion 891.
14. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004;109: 514-9.
15. Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005;6:662-72.
16. Justice USDo. Drug Enforcement Agency. Summary of Medical Examiner Reports on Oxycodone-Related Deaths, May 16. Available at: http:// www.deadiverion.usdoj.gov/drugs-concern/oxycodone/oxycodone.htm.; 2002.
17. Caravati EM, Grey T, Nangle B, et al. Increase of poisoning deaths caused by non-illicit drugs-Utah, 1991-2003. Available at: http://www.cdc.gov/ mmwr/preview/mmwrhtml/mm5402al.htm. Accessed January 21, 2005.
18. Office of Applied Studies of the Substance Abuse and Mental Health Services Administration of the U.S. Department of Health and Human Services. Results from the 2003 National Survey on Drug Use and Health: National Findings. DHHS Publication No. SMA 04-3964. Available at: http:// oas.samhsa.gov/nhsda. 2k3nsduh/2k3results.htm. Accessed March 17, 2006.
19. Zacny J, Bigelow G, Compton P, et al. College on problems of drug dependence task force on prescription opioid non-medical use and abuse: position statement. Drug and Alcohol Depend 2003;69:215-32.
20. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349:1943-53.
21. Bartleson JD. Evidence for and against the use of opioid analgesics for chronic nonmalignant low back pain: a review. Pain Med 2002;3:260-71.
22. Murphy TM. Chronic opioids for chronic low back pain-solution or problem? J Am Board Earn Pract 1996;9:225-8.
23. Portenoy RK, Savage SR. Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy-tolerance and addiction. J Pain Symptom Manage 1997;14(suppl 3):S27-S35.
24. Portenoy RK. Chronic opioid therapy in nonmalignant pain.J Pain Symptom Manage 1990;5(suppl 1):S46-S62.
25. Portenoy R, Foley K. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases. Pain 1986;25:171-86.
26. McQuay H. Opioids in pain management. Lancet 1999;353:2229-32.
27. Medicine AAoP, Society AP. The use of opioids for the treatment of chronic pain: a consensus statment. Available at: http://www.ampainsoc.org/ advovavy/opioids.htm. 1996.
28. American Pain Society. The use of opioids for the treatment of chronic pain: a consensus statement. American Pain Society. Available at: http:// www.ampainsoc.org/advovavy/opioids.htm. Accessed January 26, 2006.
29. Nedeljkovic SS, Wasan A, Jamison RN. Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain 2002;18:S39-S51.
30. Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther Drug Monit 2002;24:457-70.
31. U. S. Department of Justice. Summary of Medical Examiner Reports on Oxycodone-Related Deaths, May 16. Drug Enforcement Agency. Available at: http://www.deadiverion.usdoj.gov/drugs-concern/oxycodone/ oxycodone.htm.
32. Mercadante S, Ferrera P, Villari P,et al. Hyperalgesia: an emerging iatrogenic syndrome.J Pain Symptom Manage 2003;26:311-8.
33. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.J Pain 2006;7:43-8.
34. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995;62: 259-74.
35. Brodner RA, Taub A. Chronic pain exacerbated by long-term narcotic use in patients with nonmalignant disease: clinical syndrome and treatment. Mt Sinai J Med 1978;45:233-7.
36. Savage SR. Long-term opioid therapy: assessment of consequences and risks.J Pain Symptom Manage 1996;ll:274-86.
37. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 2002;100:213-7.
38. Turk DC, Burwinkle TM. Clinical outcomes, cost-effectiveness, and the role of psychology in treatments for chronic pain sufferers. Prof Psychol Res Pr 2005;36:602-10.
39. Harden RN. Chronic opioid therapy: another reappraisal. Aust Prosthodont Soc Bull 2002;12:1-12.
40. Maruta T, Swanson DW, Finlayson RE. Drug abuse and dependency in patients with chronic pain. Mayo Clin Proc 1979;54:241-4.
41. Maruta T, Swanson DW. Problems with the use of oxycodone compound in patients with chronic pain. Pain 1981;ll:389-96.
42. Turner JA, Calsyn DA, Fordyce WE, et al. Drug utilization patterns in chronic pain patients. Pain 1982;12:357-63.
43. Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin.J Pain Symptom Manage 1993;8: 279-88.
44. Fillingim RB, Doleys DM, Edwards RR, et al. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine 2003 28:143-50.
45. Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain.J Pain 2003;4:344-50.
46. Kidner C, Mayer T, Gatchel R. Pre-treatment dose of opioid use as a predictor of rehabilitation outcome in chronic occupational spinal disorders [in press].
47. Kidner C, Gatchel R, Mayer T. Pre-treatment level of opioid use and the MMPI disability profile [in press].
48. Mayer TG, McGeary D, Gatchel RJ. Chronic pain management through functional restoration for spinal disorders. In: Frymoyer J, Wiesel S, eds. The Adult & Pediatric Spine. 3rd ed. Philadelphia,PA: Lippincott, Williams, & Wilkins; 2004:323-33.
49. Mayer TG, Gatchel RJ, Kishino N, et al. Objective assessment of spine function following industrial injury. A prospective study with comparison group and one-year follow-up. Spine 1985;10:482-93.
50. Mayer TG, Polatin PB, Smith B, et al. Contemporary concepts in spine care: spine rehabilitation: secondary and tertiary nonoperative care. Spine 1995; 20:2060-6.
51. Mayer TG, Gatchel RJ, Mayer H, et al. A prospective two-year study of functional restoration in industrial low back injury. An objective assessment procedure. JAMA 1987;258:1763-7.
52. Mayer TG, Keeley J, Dersh J, et al. A randomized controlled trial of treatment for lumbar segmental rigidity and its association with facet syndrome. Spine J 2003;4(suppl 5):S104.
53. Mayer TG, Press J. Musculoskeletal Rehabilitation. In: Vaccaro A, ed. Chapter 55 in AAOS Orthopedic Knowledge Update (OKU-8). Chicago, IL: AAOS Press; 2004;655-60.
54. Mayer TG, Polatin P, Smith B, et al. Spine rehabilitation: secondary and tertiary nonoperative care. North American Spine Society Committee: contemporary concepts review committee. Spine J 2003;3:S28-S36.
55. Mayer TG, Gatchel RJ. Functional restoration for spinal disorders: the sports medicine approach. Philadelphia, PA: Lea 8c Febiger; 1988.
56. Hazard RG, Fenwick JW, Kalisch SM. Functional restoration with behavioral support. A one-year prospective study of patients with chronic low back pain. Spine 1989;14:157-61.
57. Bendix AE, Bendix T, Vaegter K, et al. Multidisciplinary intensive treatment for chronic low back pain: a randomized., prospective study. Cleve Clin J Med 1996;63:62-9.
58. Jousset N, Fanello S, Bontoux L, et al. Effects of functional restoration versus 3 hours per week physical therapy: a randomized controlled study. Spine 2004;29:487-93.
59. Protas EJ, Mayer TG, Dersh J, et al. Relevance of aerobic capacity measurements in the treatment of chronic work-related spinal disorders. Spine 2004; 19:2158-60.
60. Proctor T, Mayer TG, Gatchel RJ, et al. Unremitting health-care- utilization outcomes of tertiary rehabilitation of chronic musculoskeletal disorders.J Bone Joint Surg 2004;86:62-9.
61. Anagnostis C, Mayer TG, Gatchel RJ, et al. The million visual analog scale: its' utility for predicting tertiary rehabilitation outcomes. Spine 2003;28: 1051-60.
62. Bronfort G, Evans R, Nelson B, et al. A randomized clinical trial of exercise and spinal manipulation for patients with chronic neck pain. Spine 2001;26: 788-97.
63. Mayer TG, Anagnostis C, Gatchel RJ, et al. Impact of functional restoration after anterior cervical fusion on chronic disability in work-related neck pain. Spine J2002;2:267-73.
64. Mayer TG, Gatchel RJ, Evans T. Effect of age on outcomes of tertiary rehabilitation for chronic disabling spinal disorders. Spine 2001;26:1378-84.
65. Mayer TG, Prescott M, Gatchel RJ. Objective outcomes evaluation: methods and evidence. In: Mayer TG, Polatin PB, Gatchel RJ, eds. Occupational Musculoskeletal Disorders: Function, Outcomes and Evidence. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:651-67.
66. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Nonpatient Edition (SCID-I/NP, Version 2.0). New York, NY: New York State Psychiatric Institute; 1995.
67. First MB, Gibbon M, Spitzer RL, et al. User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press; 1995.
68. Dersh J, Mayer T, Theodore B, et al. Do psychiatric disorders first appear pre- or post-injury in chronic disabling occupational disorders? Spine 2007; 39:1045-51.
69. Skre I, Onstad S, Torgersen S, et al. High interrater reliability for the structured clinical interview for DSM-IH-R Axis I (SCID-I). Acta Psycbiatr Scand 1991;84:167-73.
70. Williams JBW, Gibbon M, First MB, et al. The structured clinical interview for DSM-IH-R (SCID) II: multisite test-retest reliability. Arch Gen Psychiatry 1992;49:630-6.
71. First MB, Spitzer RL, Gibbon M. The Structured clinical interview for DSM-HI-R personality disorders (SCID-II), II: multi-site test-retest reliability study.J Personal Disord 1995;9:92-104.
72. Kidorf M, Brooner RK, King VL, et al. Predictive validity of cocaine, sedative, and alcohol dependence diagnoses.J Consult Clin Psychol 1998;66: 168-73.
73. Dersh J, Gatchel RJ, Mayer TG, et al. Prevalence of psychiatric disorders in patients with chronic disabiling occupational spinal disorders. Spine 2006; 31:1156-62.
74. Longo LP, Parran T Jr, Johnson B, et al. Addiction: part II. Identification and management of the drug-seeking patient. Am Earn Physician 2000;61: 2401-8.
75. Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.J Pain Symptom Manage 2004;28:250-8.
76. Chabal C, Erjavec MK, Jacobson L, et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence and predictors. Clin J Pain 1997;13:150-5.
77. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues.J Pain Symptom Manage 1996;11:203-17.
78. Gourlay DL, Heit HA, Almahrezi A. Universal pain precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005;6:107-12.
79. Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients.J Pain Symptom Manage 2004;27:440-59.
80. Robinson RC, Gatchel RJ, Polatin PB, et al. Screening for problematic prescription opioid use. Clin J Pain 2001;17:220-8.
81. Compton P, Darakjian MA, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool.J Pain Symptom Manage 1998;16:355-63.
82. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med 2005;6: 432-42.
83. Butler SF, Budman SH, Fernandez K, et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112: 65-75.
84. Fishman SM, Wilsey B, Yang J, et al. Adherence monitoring and drug surveillance in chronic opioid therapy.J Pain Symptom Manage 2000;20:293-307.
85. Fishman SM, Kreis PG. The opioid contract. Clin J Pain 2002;18:S70-S5.
86. Savage SR. Addiction in the treatment of pain: significance, recognition, and management.J Pain Symptom Manage 1993;8:265-78.
87. Scimeca MM, Savage SR, Portenoy RK, et al. Treatment of pain in metha-done-maintained patients. Mt Sinai Med J 2000;67:412-22.
88. Turk DC, Loeser JD, Monarch ES. Chronic pain: purposes and costs of interdisciplinary pain rehabilitation programs. TEN: The Economics of Neuroscience 2002;9:64-69.
89. American Pain Society. Definitions related to the use of opioids for the treatment of pain: A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. American Pain Society. Available at: http:// www.ampainsoc.org/advocacy/opioids2.htm. Accessed September 30, 2001.
90. Compton P, Athanasos P. Chronic pain, substance abuse and addiction. Nurs Clin North Am 2003;3 8:525-31.
91. Lusher J, Elander J, Bevan D, et al. Analgesic addiction and pseudoaddiction in painful chronic illness. Clin J Pain 2006;22:316-24.
92. Passik SD, Kirsh KL, Donaghy KB, et al. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain 2006;22:173-81.